We noticed you're blocking ads.

Keep supporting great journalism by turning off your ad blocker.

Questions about why you are seeing this? Contact us

Font Size

- Aa +

Sun 5 Jul 2020 06:40 PM

Font Size

- Aa +

UAE approves Covid-19 treatment drug remdesivir

Gilead Sciences said more supply will become available in July

UAE approves Covid-19 treatment drug remdesivir

At least two major US studies have shown that the anti-viral drug can reduce the duration of hospital stays for those suffering from the novel coronavirus. Image: Gilead.

United Arab Emirates’ Ministry of Health and Prevention has granted regulatory approval to Gilead Sciences for remdesivir, the first drug shown to be relatively effective in treating Covid-19.

At least two major US studies have shown that the anti-viral drug can reduce the duration of hospital stays for those suffering from the novel coronavirus.

While there is currently limited global supply of remdesivir, Gilead said it anticipates new supply of the drug will start to become available in July, with supply continuing to increase through the end of this year and into next year.

Gilead said will work closely with the health authorities in UAE to provide guidance on anticipated drug supply based on local incidence and severity of disease.

The US government announced last week that it had bought 92 percent of all remdesivir production by the Gilead laboratory until the end of September - about 500,000 treatments out of nearly 550,000. Each treatment requires 6.25 vials on average.

Arabian Business: why we're going behind a paywall

For all the latest health tips & news from the UAE and Gulf countries, follow us on Twitter and Linkedin, like us on Facebook and subscribe to our YouTube page, which is updated daily.